Hsbc Holdings PLC Cue Biopharma, Inc. Transaction History

Hsbc Holdings PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$11.2 - $16.09 $152,924 - $219,692	-13,654 Closed	0 $0
Q4 2020 Feb 25, 2021	BUY	$11.12 - $16.4 $7,561 - $11,151	680 Added 5.24%	13,654 $0
Q3 2020 Nov 12, 2020	BUY	$15.05 - $23.54 $1,941 - $3,036	129 Added 1.0%	12,974 $201,000
Q2 2020 Aug 14, 2020	BUY	$12.7 - $30.73 $163,131 - $394,726	12,845 New	12,845 $315,000
Q1 2020 May 15, 2020	SELL	$9.85 - $22.27 $298,277 - $674,380	-30,282 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$7.06 - $17.47 $267,319 - $661,484	-37,864 Reduced 55.56%	30,282 $473,000
Q3 2019 Nov 14, 2019	BUY	$6.78 - $9.28 $462,029 - $632,394	68,146 New	68,146 $574,000

14M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $45.3M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.